The tetrapeptide acetyl-serine-aspartyl-lysine-proline improves skin flap survival and accelerates wound healing

Wound Repair and Regeneration

Volumn 14, Issue 3, 2006, Pages 306-312

  Fromes, Yves ^a   Liu, Jian Miao ^b   Kovacevic, Milica ^b   Bignon, Jérôme ^b   Wdzieczak Bakala, Joanna ^b  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; FIBRONECTIN; SERASPENIDE; TETRAPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIZATION; EXPLANT; GRANULATION TISSUE; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP; SURVIVAL; WOUND HEALING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; FIBRONECTINS; GRAFT SURVIVAL; HUMANS; KERATIN-14; MALE; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SKIN; SURGICAL FLAPS; TISSUE CULTURE TECHNIQUES; WOUND HEALING;

EID: 33745532526     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00125.x     Document Type: Article

References (31)

1. Steed DL. The role of growth factors in wound healing. Surg Clin North Am 1997; 77: 575-86.
2. Robson MC. The role of growth factors in the healing of chronic wounds. Wound Rep Reg 1997; 5: 12-7.
3. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-21 (Review).
4. Zhang F, Waller W, Lineaweaver WC. Growth factors and flap survival. Microsurgery 2004; 24: 162-7.
5. Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med 1990; 172: 245-51.
6. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomason A. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol 1992; 140: 1375-88.
7. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164: 1935-47.
8. Bayati S, Russell RC, Roth AC. Stimulation of angiogenesis to improve the viability of prefabricated flaps. Plast Reconstr Surg 1998; 101: 1290-5.
9. Pang Y, Lineaweaver WC, Lei MP, Oswald T, Shamburger S, Cai Z, Zhang F. Evaluation of the mechanism of vascular endothelial growth factor improvement of ischemic flap survival in rats. Plast Reconstr Surg 2003; 112: 556-64.
10. Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D, Aebischer P, Pepper MS. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther 2001; 8: 523-3.
11. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992; 6: 886-92 (Review).
12. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Invest Dermatol Symp Proc 2000; 5: 40-6 Review.
13. Risau W. Mechanism of angiogenesis. Nature 1997; 386: 671-4.
14. Liu JM, Lawrence F, Kovacevic M, Bignon J, Papadimitriou E, Lallemand JY, Katsoris P, Potier P, Fromes Y, Wdzieczak-Bakala J. The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 2003; 101: 3014-20.
15. Petry JJ, Wortham KA. The anatomy of the epigastric flap in the experimental rat. Plast Reconstr Surg 1984; 74: 410-3.
16. McFarlane RM, De Young G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 1965; 35: 177-82.
17. Lenfant M, Wdzieczak-Bakala J, Guittet E, Prome JC, Sotty D, Frindel E. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci USA 1989; 86: 779-82.
18. Cashman JD, Eaves AC, Eaves CJ. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism. Blood 1994; 84: 1534-42.
19. Huang WQ, Wang QR. Bone marrow endothelial cells secrete thymosin beta4 and AcSDKP. Exp Hematol 2001; 29: 12-8.
20. Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D, Aebischer P, Pepper MS. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther 2001; 8: 523-3.
21. Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000; 53: 234-9.
22. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24 (Review).
23. Paladini RD, Coulombe PA. The functional diversity of epidermal keratins revealed by the partial rescue of the keratin 14 null phenotype by keratin 16. J Cell Biol 1999; 146: 1185-201.
24. Hutton E, Paladini RD, Yu QC, Yen M, Coulombe PA, Fuchs E. Functional differences between keratins of stratified and simple epithelia. J Cell Biol 1998; 143: 487-99.
25. Grinell F. Fibronectin and wound healing. J Cell Biochem 1984; 26: 107-16.
26. Clark RA. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol 1990; 94: 128S-34.
27. Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK. Thymosin beta4 accelerates wound healing. J Invest Dermatol 1999; 113: 364-8.
28. Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK. Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Rep Reg 2003; 11: 19-24.
29. Lenfant M, Grillon C, Rieger KJ, Sotty D, Wdzieczak-Bakala J. Formation of acetyl-Ser-Asp-Lys-Pro, a new regulator of the hematopoietic system, through enzymatic processing of thymosin beta 4. Ann N Y Acad Sci 1991; 628: 115-2.
30. Bonnet D, Lemoine FM, Frobert Y, Bonnet ML, Baillou C, Najman A, Guigon M. Thymosin beta 4, inhibitor for normal hematopoietic progenitor cells. Exp Hematol 1996; 24: 776-82.
31. Philp D, Goldstein AL, Kleinman HK. Thymosin beta 4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev 2004; 125: 113-5.